Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical TrialJ. Andrew Bird, A. Wesley Burks, Amal Assa’ad et al.|The Journal of Allergy and Clinical Immunology In Practice|2017Cited by 200
Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial ResultsJacqueline A. Pongracic, Philippe Bégin, Rémi Gagnon et al.|The Journal of Allergy and Clinical Immunology In Practice|2021Cited by 61